NOVANEX SOLUTIONS LLC – Trademark Portfolio

Entity Type: 22

NOVANEX SOLUTIONS LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include QUORINTHIUMAX. The owner is based in ATLANTA, GA.

2085 MOREHOUSE DR NW

ATLANTA, GA 30314

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NOVANEX SOLUTIONS LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does NOVANEX SOLUTIONS LLC have?

NOVANEX SOLUTIONS LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does NOVANEX SOLUTIONS LLC file in?

NOVANEX SOLUTIONS LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NOVANEX SOLUTIONS LLC's most well-known trademarks?

NOVANEX SOLUTIONS LLC's registered trademark portfolio includes well-known marks such as QUORINTHIUMAX. These are among 2 currently registered trademarks in the portfolio.

What is NOVANEX SOLUTIONS LLC's trademark registration success rate?

NOVANEX SOLUTIONS LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.